Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Lack of Anti-A Hæmagglutinin Response to Influenza Infection

Abstract

McDonald and Zuckerman have reported1 an excess of blood group O and a corresponding deficiency of group A among patients with influenza A2 infection. Blood group A-like antigens have been found in commercial influenza vaccines2, and injection of non-dialysable material from such vaccines has given 4- to 15-fold increases in anti-A titres3.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. McDonald, J. C., and Zuckerman, A. J., Brit. Med. J., ii, 89 (1962).

  2. Springer, G. F., and Tritel, H., Science, 138, 687 (1962).

    Article  ADS  CAS  Google Scholar 

  3. Springer, G. F., Transfusion, 3, 233 (1963).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

FAGERHOL, M., HARBOE, A. & HARTMANN, O. Lack of Anti-A Hæmagglutinin Response to Influenza Infection. Nature 203, 1185–1186 (1964). https://doi.org/10.1038/2031185a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/2031185a0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing